AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwal's Health Care has submitted its Annual Secretarial Compliance Report for FY2024-25, as required under SEBI's Listing Regulations. Practising Company Secretary Subramanian Chandrasekar reviewed the company's filings, records, and disclosures for the year and confirmed full compliance with SEBI regulations, secretarial standards, insider trading rules, related party transaction norms, and corporate governance requirements. No SEBI or stock exchange actions were taken against the company, its promoters, or directors during the year. One minor observation was noted: a delay in reporting orders passed by the Income Tax Department levying a penalty against the company under Regulation 30 of SEBI LODR. The company was newly listed during FY2024-25, so no prior-year observations apply.
This is a routine annual compliance filing with no material adverse findings, suggesting clean governance standards. The only flag is a delayed disclosure of an Income Tax penalty order, which investors may want to track for further details on the quantum and status of the penalty.